Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $23.9B |
| Sales growthchange from the year before | +22.0% |
| Net marginshare of sales kept as profit | 0.0% |
| Free-cash-flow marginspare cash generated per $100 of sales | 36.6% |
| Return on equityprofit vs. shareholders' accounting value | 0.0% |
| Change in share countnegative = the company is buying back its shares | -1.4% |
7 insiders sold $77.2M (9% under pre-arranged plans) on the open market.
| Schwab-Pomerantz CarolynDirector | SoldAug 4 | 22,640 shat $106.36 · $2.4M |
| Schwab Charles R.Co-Chairman · Director | SoldAug 4 | 47,650 shat $106.08 · $5.1M |
| Schwab Charles R.Co-Chairman · Director | SoldAug 3 | 95,250 shat $105.52 · $10.1M |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy